Trials / Completed
CompletedNCT03444818
A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants
A Phase I, Open-label, Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- EA Pharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to evaluate the absorption, metabolism, and excretion of a single oral dose of \[14C\]-E6007 in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-E6007 | Oral administration |
Timeline
- Start date
- 2018-04-17
- Primary completion
- 2018-06-26
- Completion
- 2018-06-26
- First posted
- 2018-02-23
- Last updated
- 2018-08-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03444818. Inclusion in this directory is not an endorsement.